Aspirin regulates SNARE protein expression and phagocytosis in dendritic cells

2011 ◽  
Vol 28 (2) ◽  
pp. 90-102 ◽  
Author(s):  
Deyu Tarika Cai ◽  
Yong Hou Sunny Ho ◽  
Kher Hsin Chiow ◽  
Seok Hui Wee ◽  
Yulan Han ◽  
...  
Glia ◽  
2011 ◽  
Vol 59 (10) ◽  
pp. 1472-1488 ◽  
Author(s):  
Vanessa Schubert ◽  
David Bouvier ◽  
Andrea Volterra

2020 ◽  
Vol 2020 ◽  
pp. 1-15
Author(s):  
Xiangguo Duan ◽  
Yaru Lan ◽  
Xiaoyu Zhang ◽  
Shaozhang Hou ◽  
Jian Chen ◽  
...  

In previous studies, Lycium barbarum polysaccharides (LBP), a traditional Chinese medicine, can promote immature dendritic cells (DCs) to mature. However, the molecular mechanisms by which LBP works are not yet elucidated. Here, we found that LBP can induce DCs maturation, which is mainly characterized by the upregulation of MHCII and costimulatory molecules (CD80, CD86), and increase the production of IL-6 and IL-4. Furthermore, we found that LBP could increase the mRNA and protein expression of TLR4, p38, Erk1/2, JNK, and Blimp1 signal molecules. More interestingly, after blocking by Toll-like receptor 4 inhibitor, Resatorvid (TAK 242), the mRNA and protein expression of TLR4, Erk1/2, and Blimp1 was significantly decreased while the expression of p38 and JNK has not changed. Then, we found that after blocking by p38 inhibitor (SB203580), Erk inhibitor (PD98059), and JNK inhibitor (SP603580) separately, Blimp1 protein expression was significantly reduced; after downregulating Blimp1 by Blimp1-siRNA, the production of IL-6 was reduced. In conclusion, our results indicate that LBP can induce maturation of DCs through the TLR4-Erk1/2-Blimp1 signal pathway instead of the JNK/p38-Blimp1 pathway. Our findings may provide a novel evidence for understanding the molecular mechanisms of LBP on activating murine DCs.


2012 ◽  
Vol 42 (2) ◽  
pp. 470-475 ◽  
Author(s):  
Varsha Pattu ◽  
Bin Qu ◽  
Eva C. Schwarz ◽  
Bettina Strauß ◽  
Lisa Weins ◽  
...  

Diabetes ◽  
1999 ◽  
Vol 48 (5) ◽  
pp. 997-1005 ◽  
Author(s):  
C. B. Chan ◽  
R. M. MacPhail ◽  
L. Sheu ◽  
M. B. Wheeler ◽  
H. Y. Gaisano

2015 ◽  
Vol 2015 ◽  
pp. 1-15 ◽  
Author(s):  
Paula Laranjeira ◽  
Joana Gomes ◽  
Susana Pedreiro ◽  
Monia Pedrosa ◽  
Antonio Martinho ◽  
...  

The immunosuppressive properties of mesenchymal stromal/stem cells (MSC) rendered them an attractive therapeutic approach for immune disorders and an increasing body of evidence demonstrated their clinical value. However, the influence of MSC on the function of specific immune cell populations, namely, monocyte subpopulations, is not well elucidated. Here, we investigated the influence of human bone marrow MSC on the cytokine and chemokine expression by peripheral blood classical, intermediate and nonclassical monocytes, and myeloid dendritic cells (mDC), stimulated with lipopolysaccharide plus interferon (IFN)γ. We found that MSC effectively inhibit tumor necrosis factor- (TNF-)αand macrophage inflammatory protein- (MIP-) 1βprotein expression in monocytes and mDC, without suppressing CCR7 and CD83 protein expression. Interestingly, mDC exhibited the highest degree of inhibition, for both TNF-αand MIP-1β, whereas the reduction of TNF-αexpression was less marked for nonclassical monocytes. Similarly, MSC decreased mRNA levels of interleukin- (IL-) 1βand IL-6 in classical monocytes, CCL3, CCL5, CXCL9, and CXCL10 in classical and nonclassical monocytes, and IL-1βand CXCL10 in mDC. MSC do not impair the expression of maturation markers in monocytes and mDC under our experimental conditions; nevertheless, they hamper the proinflammatory function of monocytes and mDC, which may impede the development of inflammatory immune responses.


Sign in / Sign up

Export Citation Format

Share Document